Literature DB >> 4615258

[IgG- and IgM antibodies as diagnostic criteria for toxoplasmoses (author's transl)].

I Braveny, R Disko, H Mussnig.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4615258     DOI: 10.1007/bf02121447

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  7 in total

1.  EVALUATION OF IMMUNOFLUORESCENT AND DIRECT AGGLUTINATION METHODS FOR DETECTION OF SPECIFIC TOXOPLASMA ANTIBODIES.

Authors:  J D FULTON; A VOLLER
Journal:  Br Med J       Date:  1964-11-07

2.  Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis.

Authors:  R F Dorfman; J S Remington
Journal:  N Engl J Med       Date:  1973-10-25       Impact factor: 91.245

3.  IgM antibodies in acute toxoplasmosis. I. Diagnostic significance in congenital cases and a method for their rapid demonstration.

Authors:  J S Remington; M J Miller; I Brownlee
Journal:  Pediatrics       Date:  1968-06       Impact factor: 7.124

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  [Demonstration of IgM-antitoxoplasma antibodies in acute and chronic acquired human toxoplasmosis].

Authors:  E Thiermann; S Stagno
Journal:  Zentralbl Bakteriol Orig A       Date:  1972-02

6.  19S and 7S anti-toxoplasma antibodies in diagnosis of acute congenital and acquired toxoplasmosis.

Authors:  J S Remington; M J Miller
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

7.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.

Authors:  S E SVEHAG; B MANDEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

  7 in total
  1 in total

1.  [Antibody differentiation in human toxoplasmosis experiments on model cases (author's transl)].

Authors:  F Müller; P Klein
Journal:  Med Microbiol Immunol       Date:  1975-12-30       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.